President and CSO of Centagen.
Bryant Villeponteau, Ph.D. has 30 years of scientific leadership experience and about 60 journal and patent publications. Dr. Villeponteau holds a B.A. in Economics, a M.A. in Biostatistics, and a Ph.D. in Molecular Biology from UCLA. Bryant was Assistant Research Chemist in the Department of Chemistry and Biochemistry at UCLA for 4 years and Assistant Professor of Biological Chemistry at the University of Michigan Medical School for 6 years. Bryant then led a research group at Geron Corporation for 4.5 years, where he was the lead inventor in cloning human telomerase, thereby wining the Distinguished Inventor Award for the 2nd best US patent of 1997. As the Champion of Telomerase Therapeutics at Geron, he also worked on human stem cells, which were pioneered by Geron in the 90s. Bryant then joined HealthSpan Sciences, Inc. as CSO and later served as CEO for three years. For the next 8 years, Dr. Villeponteau served as a VP/consultant for Sierra Sciences. From September of 2008 to present, Dr. Villeponteau has been the VP of R & D with Genescient Corporation. Bryant also cofounded Centagen, incorporated in January of 2009, and Life Code LLC in October of 2010 to market Stem Cell 100TM.
Visit website: http://centagen.com/company.html
See also: Centagen - Company developing multi-path therapeutics for age-related disorders via activating adult stem cells
Bryant Villeponteau News
Organ, tissue replacement could end aging by mid-2020s
Institute for Ethics and Emerging Technologies (IEET) - 14-May-2013Read more...